APA (7th ed.) Citation

Murray, A., Gough, G., Cindrić, A., Vučković, F., Koschut, D., Borelli, V., . . . Nižetić, D. (2023). Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels. EBioMedicine, 94, 104692. https://doi.org/10.1016/j.ebiom.2023.104692

Chicago Style (17th ed.) Citation

Murray, Aoife, et al. "Dose Imbalance of DYRK1A Kinase Causes Systemic Progeroid Status in Down Syndrome by Increasing the Un-repaired DNA Damage and Reducing LaminB1 Levels." EBioMedicine 94 (2023): 104692. https://doi.org/10.1016/j.ebiom.2023.104692.

MLA (9th ed.) Citation

Murray, Aoife, et al. "Dose Imbalance of DYRK1A Kinase Causes Systemic Progeroid Status in Down Syndrome by Increasing the Un-repaired DNA Damage and Reducing LaminB1 Levels." EBioMedicine, vol. 94, 2023, p. 104692, https://doi.org/10.1016/j.ebiom.2023.104692.